Inovalon Stock Forecast, Price & News

Inovalon's stock was trading at $17.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, INOV stock has increased by 52.0% and is now trading at $26.38.
View which stocks have been most impacted by COVID-19.

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares.
View analyst ratings for Inovalon or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Inovalon a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Inovalon wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Inovalon.

Inovalon will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Inovalon Holdings, Inc. (NASDAQ:INOV) issued its quarterly earnings results on Wednesday, October, 28th. The technology company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.04. The technology company earned $161.38 million during the quarter, compared to the consensus estimate of $179.27 million. Inovalon had a return on equity of 9.07% and a net margin of 0.87%.
View Inovalon's earnings history.

Inovalon issued an update on its FY21 earnings guidance on Monday, January, 11th. The company provided earnings per share (EPS) guidance of $0.73-0.75 for the period, compared to the Thomson Reuters consensus estimate of $0.63. The company issued revenue guidance of $741-768 million, compared to the consensus revenue estimate of $749.45 million.

9 equities research analysts have issued 1-year target prices for Inovalon's shares. Their forecasts range from $15.00 to $30.00. On average, they expect Inovalon's share price to reach $24.11 in the next twelve months. This suggests that the stock has a possible downside of 8.6%.
View analysts' price targets for Inovalon or view Wall Street analyst' top-rated stocks.

Some companies that are related to Inovalon include Autohome (ATHM), Five9 (FIVN), Pegasystems (PEGA), Zynga (ZNGA), Globant (GLOB), Proofpoint (PFPT), Change Healthcare (CHNG), JOYY (YY), DXC Technology (DXC), CoreLogic (CLGX), LiveRamp (RAMP), Upwork (UPWK), Perspecta (PRSP), 8X8 (EGHT) and CarGurus (CARG).
View all of INOV's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

(INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Inovalon's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Spence Asset Management (0.24%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon.

INOV stock was sold by a variety of institutional investors in the last quarter, including Spence Asset Management. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Robert A Wychulis.
View insider buying and selling activity for Inovalon or view top insider-selling stocks.

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of INOV stock can currently be purchased for approximately $26.38.

Inovalon has a market capitalization of $4.10 billion and generates $642.41 million in revenue each year. The technology company earns $7.78 million in net income (profit) each year or $0.41 on an earnings per share basis. Inovalon employs 2,662 workers across the globe.

The official website for Inovalon is www.inovalon.com.

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]